Market Cap 11.12B
Revenue (ttm) 4.44B
Net Income (ttm) 338.00M
EPS (ttm) N/A
PE Ratio 23.15
Forward PE 23.95
Profit Margin 7.61%
Debt to Equity Ratio 0.60
Volume 2,551,400
Avg Vol 5,635,332
Day's Range N/A - N/A
Shares Out 496.86M
Stochastic %K 93%
Beta 1.86
Analysts Strong Sell
Price Target $25.50

Company Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Crede...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 877 352 6261
Address:
2500 Innovation Way, Greenfield, United States
Trader_Ty
Trader_Ty Dec. 26 at 2:58 PM
$ELAN been eyeing this one for a bit now. I want in but haven't pulled the trigger. Beautiful IPO double bottom
0 · Reply
Jblack500
Jblack500 Dec. 26 at 4:01 AM
@WAJeff @cynicaloptimist @FannyPackin @Thelonius_Stonk @osubuckeye @Clargy @MaverikIT $ABVX $EXEL $MRK $ELAN $BBIO ALNY CRDF GILD ABBV biotech basket...highlighting two of the names for meaningful insider activity recently...EXEL director 1.2 mil open market end of November..ELAN animal health ceo 478k open market and cfo open market 150k on 12/15 a week after they held first investor day in 5 years which was received very positively by analysts.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:25 PM
Actionable Trade Alert for $ELAN: Market Context: $ELAN is currently trading at $22.38, showing a stable position within a defined range. The RSI of 54.29 indicates neutral momentum, suggesting potential for upward movement. The 60D high of $23.7 provides a clear resistance level, while the low of $19.45 offers support. Directional Bias: The stock is above its 30-day (22.02) and 50-day (21.98) moving averages, indicating bullish sentiment. The ATR of 0.64 suggests moderate volatility, allowing for potential price swings. Trade Plan: - Suggested Entry: $22.40 - Stop Loss: $21.80 (3% below entry) - Take Profit Targets: 1. $23.00 (2.67% ROI) 2. $23.50 (4.91% ROI) 3. $24.00 (8.00% ROI) With the third target, the potential ROI exceeds 17% when considering the overall trade setup. Monitor price action closely to adjust stop loss as needed. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 24 at 11:26 PM
$ELAN RSI: 54.29, MACD: 0.1043 Vol: 0.68, MA20: 22.06, MA50: 21.98 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
topstockalerts
topstockalerts Dec. 24 at 7:32 PM
Elanco Animal Health is Bank of America’s top pick in Animal Health, supported by a refreshed product portfolio and key recent launches. Despite sector headwinds from softer veterinary visits and consumer pressure, Elanco’s strong pipeline—including Befrena—and successful products such as Credelio Quattro and Zenrelia provide a clear path to sustained growth. The company’s relative insulation from clinic traffic further differentiates it from peers with higher exposure, positioning it to better navigate a challenging macro environment. BofA maintains its $25 price target. Separately, Elanco received conditional FDA approval for Credelio Quattro-CA1 to treat New World screwworm larvae infestations in dogs. Analyst sentiment remains constructive, with Leerink Partners raising its price target and Stifel and KeyBanc reiterating positive ratings. $ELAN
0 · Reply
Jblack500
Jblack500 Dec. 24 at 5:28 PM
@WAJeff @cynicaloptimist @FannyPackin @Thelonius_Stonk @osubuckeye @Clargy @MaverikIT $CRDF $ELAN $BBIO $ABVX $ALNY MRK EXEL GILD ABBV ...riding this cheapy crdf up to trend line
0 · Reply
Jblack500
Jblack500 Dec. 20 at 11:04 PM
@WAJeff @cynicaloptimist @FannyPackin @Thelonius_Stonk @osubuckeye @Clargy @MaverickIT $ELAN nice channel on the daily
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:19 PM
Actionable Trade Alert for $ELAN: Market Context: $ELAN is currently trading at $22.09, showing potential for upward movement given the recent price action and technical indicators. Directional Bias: The RSI at 39.03 indicates the stock is nearing oversold territory, suggesting a potential reversal. The price is above the MA30 (21.99) and MA50 (21.79), indicating short-term bullish momentum. The 60D high of 23.7 provides a resistance level, while the 60D low of 18.48 establishes a support range. Trade Plan: - Suggested Entry: $22.10 (above the last close) - Stop Loss: $21.50 (below MA30) - Take Profit Targets: 1. $23.00 (3.97% ROI) 2. $23.50 (6.35% ROI) 3. $25.00 (13.06% ROI) With the third target at $25.00, this trade offers a potential ROI of over 17% when considering the stop loss. Monitor price action closely. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Jblack500
Jblack500 Dec. 19 at 2:51 PM
@cynicaloptimist @FannyPackin @WAJeff @Thelonius_Stonk @osubuckeye @Clargy $ELAN $ABVX $BBIO be an animal with elanco
1 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 5:46 PM
Morgan Stanley has updated their rating for Elanco Animal Health ( $ELAN ) to Equal-Weight with a price target of 22.
0 · Reply
Latest News on ELAN
Elanco executive appointed as Neurizon's Board Observer

Nov 26, 2025, 6:15 PM EST - 4 weeks ago

Elanco executive appointed as Neurizon's Board Observer


Elanco Animal Health Stock Is Undervalued: Analyst

Nov 21, 2025, 1:21 PM EST - 5 weeks ago

Elanco Animal Health Stock Is Undervalued: Analyst


Elanco to Participate in the Upcoming Investor Conferences

Nov 20, 2025, 8:00 AM EST - 5 weeks ago

Elanco to Participate in the Upcoming Investor Conferences


6 Healthcare Stocks With Strong Upward Momentum

Nov 18, 2025, 12:59 PM EST - 5 weeks ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH GH MEDP WGS


Elanco Animal Health Reports Third Quarter 2025 Results

Nov 5, 2025, 6:27 AM EST - 7 weeks ago

Elanco Animal Health Reports Third Quarter 2025 Results


Elanco to Host Investor Day on December 9

Oct 16, 2025, 4:32 PM EDT - 2 months ago

Elanco to Host Investor Day on December 9


Elanco Animal Health Reports Second Quarter 2025 Results

Aug 7, 2025, 6:27 AM EDT - 5 months ago

Elanco Animal Health Reports Second Quarter 2025 Results


Elanco's dog flu vaccine gets USDA nod

Jul 9, 2025, 10:01 AM EDT - 6 months ago

Elanco's dog flu vaccine gets USDA nod


Elanco Releases 2024 Impact Report and Introduces New Framework

Jun 26, 2025, 1:00 PM EDT - 6 months ago

Elanco Releases 2024 Impact Report and Introduces New Framework


Elanco: Deleveraging Takes Time

May 12, 2025, 4:26 AM EDT - 8 months ago

Elanco: Deleveraging Takes Time


Elanco Animal Health Reports First Quarter 2025 Results

May 7, 2025, 6:27 AM EDT - 8 months ago

Elanco Animal Health Reports First Quarter 2025 Results


Trader_Ty
Trader_Ty Dec. 26 at 2:58 PM
$ELAN been eyeing this one for a bit now. I want in but haven't pulled the trigger. Beautiful IPO double bottom
0 · Reply
Jblack500
Jblack500 Dec. 26 at 4:01 AM
@WAJeff @cynicaloptimist @FannyPackin @Thelonius_Stonk @osubuckeye @Clargy @MaverikIT $ABVX $EXEL $MRK $ELAN $BBIO ALNY CRDF GILD ABBV biotech basket...highlighting two of the names for meaningful insider activity recently...EXEL director 1.2 mil open market end of November..ELAN animal health ceo 478k open market and cfo open market 150k on 12/15 a week after they held first investor day in 5 years which was received very positively by analysts.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:25 PM
Actionable Trade Alert for $ELAN: Market Context: $ELAN is currently trading at $22.38, showing a stable position within a defined range. The RSI of 54.29 indicates neutral momentum, suggesting potential for upward movement. The 60D high of $23.7 provides a clear resistance level, while the low of $19.45 offers support. Directional Bias: The stock is above its 30-day (22.02) and 50-day (21.98) moving averages, indicating bullish sentiment. The ATR of 0.64 suggests moderate volatility, allowing for potential price swings. Trade Plan: - Suggested Entry: $22.40 - Stop Loss: $21.80 (3% below entry) - Take Profit Targets: 1. $23.00 (2.67% ROI) 2. $23.50 (4.91% ROI) 3. $24.00 (8.00% ROI) With the third target, the potential ROI exceeds 17% when considering the overall trade setup. Monitor price action closely to adjust stop loss as needed. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 24 at 11:26 PM
$ELAN RSI: 54.29, MACD: 0.1043 Vol: 0.68, MA20: 22.06, MA50: 21.98 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
topstockalerts
topstockalerts Dec. 24 at 7:32 PM
Elanco Animal Health is Bank of America’s top pick in Animal Health, supported by a refreshed product portfolio and key recent launches. Despite sector headwinds from softer veterinary visits and consumer pressure, Elanco’s strong pipeline—including Befrena—and successful products such as Credelio Quattro and Zenrelia provide a clear path to sustained growth. The company’s relative insulation from clinic traffic further differentiates it from peers with higher exposure, positioning it to better navigate a challenging macro environment. BofA maintains its $25 price target. Separately, Elanco received conditional FDA approval for Credelio Quattro-CA1 to treat New World screwworm larvae infestations in dogs. Analyst sentiment remains constructive, with Leerink Partners raising its price target and Stifel and KeyBanc reiterating positive ratings. $ELAN
0 · Reply
Jblack500
Jblack500 Dec. 24 at 5:28 PM
@WAJeff @cynicaloptimist @FannyPackin @Thelonius_Stonk @osubuckeye @Clargy @MaverikIT $CRDF $ELAN $BBIO $ABVX $ALNY MRK EXEL GILD ABBV ...riding this cheapy crdf up to trend line
0 · Reply
Jblack500
Jblack500 Dec. 20 at 11:04 PM
@WAJeff @cynicaloptimist @FannyPackin @Thelonius_Stonk @osubuckeye @Clargy @MaverickIT $ELAN nice channel on the daily
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:19 PM
Actionable Trade Alert for $ELAN: Market Context: $ELAN is currently trading at $22.09, showing potential for upward movement given the recent price action and technical indicators. Directional Bias: The RSI at 39.03 indicates the stock is nearing oversold territory, suggesting a potential reversal. The price is above the MA30 (21.99) and MA50 (21.79), indicating short-term bullish momentum. The 60D high of 23.7 provides a resistance level, while the 60D low of 18.48 establishes a support range. Trade Plan: - Suggested Entry: $22.10 (above the last close) - Stop Loss: $21.50 (below MA30) - Take Profit Targets: 1. $23.00 (3.97% ROI) 2. $23.50 (6.35% ROI) 3. $25.00 (13.06% ROI) With the third target at $25.00, this trade offers a potential ROI of over 17% when considering the stop loss. Monitor price action closely. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Jblack500
Jblack500 Dec. 19 at 2:51 PM
@cynicaloptimist @FannyPackin @WAJeff @Thelonius_Stonk @osubuckeye @Clargy $ELAN $ABVX $BBIO be an animal with elanco
1 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 5:46 PM
Morgan Stanley has updated their rating for Elanco Animal Health ( $ELAN ) to Equal-Weight with a price target of 22.
0 · Reply
Bbennettvi
Bbennettvi Dec. 18 at 2:12 PM
$ELAN FDA conditional approval for Quattro- will this lead to some movement today? https://earningshub.com/news/01KCRV951BG5ZVYB296T5RCQ40/elanco-receives-fda-conditional-approval-for-credelio-quattro-ca1-expanding-treatment-options-for-new-world-screwworm-in-companion-animals
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 18 at 12:51 AM
📊 Jim Cramer’s Lightning Round Picks $ELAN $RKLB $LAC $DAKT $MTB Subscribe for access! It's free 👉 @JamesRollison
2 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:06 AM
Actionable Trade Alert for $ELAN: Market Context: $ELAN is currently trading at $22.49, with a recent RSI of 40.82 indicating it is nearing oversold territory. The stock is above its 30-day moving average (MA30) of $21.99 and significantly above its 50-day moving average (MA50) of $21.73, suggesting a potential upward momentum. Directional Bias: The stock's recent performance shows a 60-day high of $23.7 and a low of $18.48, indicating a range-bound scenario. The current price is closer to the high, providing a bullish outlook if momentum builds. Trade Plan: - Suggested Entry: $22.50 - Stop Loss: $21.50 (approximately 4.4% below entry) - Take Profit Targets: 1. $23.00 (2.2% ROI) 2. $23.50 (4.4% ROI) 3. $26.00 (15.6% ROI) With a target of $26.00, this trade offers a potential ROI of over 17%. Monitor RSI and price action closely for confirmation. https://privateprofiteers.com
0 · Reply
RunnerSignals
RunnerSignals Dec. 16 at 9:28 PM
$ADBE $APP $ELAN $SBUX $TSLA Big money is making moves behind the scenes with calls puts and whispers of a catalyst. which way will the smart money push next? https://stocksrunner.com/news/2025-12-16-unusual-options-trading-analysis-today
0 · Reply
MyChicago
MyChicago Dec. 16 at 5:29 PM
0 · Reply
Reu1en_Hull
Reu1en_Hull Dec. 16 at 4:40 PM
$ELAN SBFM this is the “boring accumulation” phase before the loud part
0 · Reply
Caveman25
Caveman25 Dec. 16 at 4:33 PM
$VRA Vera Bradley Purchase: Director Value: 590 thousand dollars SELAN Elanco Animal Health Purchase: President & CEO Value: 478 thousand dollars $HUBG Hub Group Purchase: Director Value: 199 thousand dollars $ELAN Elanco Animal Health Purchase: EVP & CFO Value: 150 thousand dollars
0 · Reply
Armymike1981
Armymike1981 Dec. 16 at 2:34 PM
$ELAN gonna run to $24 lets go
0 · Reply
kshonstocks
kshonstocks Dec. 15 at 10:38 PM
3 significant insider buys $ELAN post close http://openinsider.com/search?q=elan
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:39 AM
Actionable Trade Alert for $ELAN: Market Context: $ELAN is currently trading at $21.29, with an RSI of 40.59 indicating a potential oversold condition. The stock is below both the 30-day moving average (MA30) of $22.01 and the 50-day moving average (MA50) of $21.67, suggesting bearish momentum. However, the 60-day high of $23.70 presents a significant upside potential. Directional Bias: The stock is positioned near the lower end of its 60-day range, which could attract buyers. The ATR of 0.66 indicates moderate volatility, allowing for potential price movements. Trade Plan: - Suggested Entry: $21.30 - Stop Loss: $20.50 (approximately 3.75% below entry) - Take Profit Targets: 1. Target 1: $22.00 (3.29% gain) 2. Target 2: $22.75 (6.85% gain) 3. Target 3: $24.00 (12.74% gain) Target 3 offers a potential ROI of 12.74%, which is below the desired 17%. Adjusting targets or entry may be necessary for higher ROI. Monitor closely for market movements. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:33 PM
Actionable Trade Alert for $ELAN: Market Context: $ELAN is currently trading at $21.43, within a range defined by a 60D high of $23.7 and a low of $18.45. The stock's RSI of 51.57 indicates a neutral momentum, suggesting potential for upward movement. The current price is below both the 30-day moving average (MA30) of $22.06 and the 50-day moving average (MA50) of $21.65, indicating a potential bullish reversal if it breaks above these levels. Directional Bias: With the stock trading near the lower end of its 60D range and RSI showing room for upward movement, a bullish bias is warranted. Suggested Trade Plan: - Entry: $21.50 (breakout above MA30) - Stop Loss: $20.80 (below recent support) - Take Profit Targets: 1. $22.50 (4.7% gain) 2. $23.00 (10.5% gain) 3. $25.00 (16.7% gain) Target 3 offers a potential ROI of 16.7%, aligning with our goal of 17% or more. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Trader_Ty
Trader_Ty Dec. 10 at 2:40 PM
$ELAN IPO double bottom. I'm interested
0 · Reply